Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-12T19:14:00.668Z Has data issue: false hasContentIssue false

Fecal microbiota transplantation results in durable long-term engraftment of donor derived anaerobic taxa and MDRO decolonization

Published online by Cambridge University Press:  23 June 2026

Ahmed Babiker
Affiliation:
Rush Medical Center
Sarah Lohsen
Affiliation:
Emory University
Colleen Kraft
Affiliation:
Emory University Hospital
Sarah Satola
Affiliation:
Emory University School of Medicine
Michael Woodworth
Affiliation:
Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, GA

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Background: Microbiome restoration through fecal microbiota transplantation (FMT) is a promising decolonization strategy that reduces multidrug-resistant organism (MDRO) colonization and infection. However, the strains mediating MDRO decolonization remain poorly defined, and long-term follow-up (LTF) data after FMT for MDRO decolonization are limited. We enrolled participants from a completed randomized trial of FMT for MDRO decolonization (PREMIX, NCT02922816) into an LTF study to characterize long-term engraftment dynamics of donor-derived anaerobic taxa and their association with sustained MDRO decolonization. Methods: Participants provided stool samples every six months for up to five years following completion of the trial. Samples underwent selective culturing for MDROs using chromogenic agars, with organism identification and susceptibility confirmation by MALDI-TOF and Vitek2. MDRO isolates underwent whole-genome sequencing (WGS), and stool samples underwent metagenomic sequencing. To determine similarity between baseline and LTF MDROs, pairwise comparison of baseline and LTF MDRO isolates was performed with a unique strain defined as < 99.5% average nucleotide identify difference (ANI) to other strains. To determine engraftment of donor derived anaerobic taxa construction of metagenome-assembled genomes (MAG) from donor and participants samples was performed. Donor MAGs detected at <50% breadth in LTF metagenome samples were compared to corresponding species-level MAGs from participant LTF samples, with unique MAGs defined as <99.5% ANI like strains above Results Six PREMIX participants were enrolled to the LTF study, five of whom received FMT and one control. 80% (4/5) of FMT treated patients have remained decolonized (culture negative) while 0% (0/1) of control patients have remained decolonized at most recent follow up (median[IQR] 3.6 [3.4,4.0] years). The single FMT-treated participant with MDRO detection in LTF samples had evidence of a new acquisition compared to the baseline MDRO, whereas the MDRO detected in the control participant was identical to the baseline strain based on ANI cut offs. Among FMT-treated participants, metagenomic analysis demonstrated persistent detection of donor-derived anaerobic strains at <50% breadth, with high ANI between donor MAGs and participant LTF MAGs for multiple key taxa, including Acetatifactor sp., Akkermansia muciniphila, Alistipes putredinis, Barnesiella intestinihominis, Eubacterium siraeum, Mesosutterella massiliensis, Odoribacter splanchnicus, and Phascolarctobacterium faecium, consistent with long-term engraftment (Figure 1). No donor-derived MAGs were detected in control participants at <99.5% ANI. Conclusions: FMT was associated with long-term durable decolonization potentially mediated by the engraftment and persistence of key donor derived anaerobic strains. Our findings of persistence of discrete taxa highlights the potential for developing rationally constructed strain-based microbiome therapeutics for decolonization and infection prevention.

Multiple bar graphs depict donor-strain engraftment breadth across selected anaerobic taxa following fecal microbiota transplantation (FMT).

Information

Type
Decolonization Strategies
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America